Vanda Pharmaceuticals Inc. - VNDA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | — | A | A | 57,101.0 | 0.0 | 0.0 | 57,101.0 | View | |
| Mar 04, 2026 | President and CEO | S | D | 156,235.0 | 8.1734 | 1,276,971.15 | 2,704,496.0 | View | |
| Mar 04, 2026 | SVP & General Counsel | S | D | 42,434.0 | 8.2659 | 350,755.2 | 377,450.0 | View | |
| Mar 04, 2026 | SVP, Chief Marketing Officer | S | D | 30,800.0 | 8.2659 | 254,589.72 | 333,469.0 | View | |
| Mar 04, 2026 | SVP, CFO & Treasurer | S | D | 42,442.0 | 8.2659 | 350,821.33 | 411,380.0 | View | |
| Mar 04, 2026 | SVP, Business Development | S | D | 42,431.0 | 8.2659 | 350,730.4 | 494,197.0 | View | |
| Feb 24, 2026 | — | S | D | 30,000.0 | 8.03 | 240,900.0 | 93,469.0 | View | |
| Feb 19, 2026 | SVP, Chief Marketing Officer | A | A | 125,000.0 | 0.0 | 0.0 | 364,269.0 | View | |
| Feb 19, 2026 | SVP, Business Development | A | A | 125,000.0 | 0.0 | 0.0 | 536,628.0 | View | |
| Feb 19, 2026 | SVP & General Counsel | A | A | 125,000.0 | 0.0 | 0.0 | 419,884.0 | View | |
| Feb 19, 2026 | SVP, CFO & Treasurer | A | A | 125,000.0 | 0.0 | 0.0 | 453,822.0 | View | |
| Feb 19, 2026 | President and CEO | A | A | 525,000.0 | 0.0 | 0.0 | 2,860,731.0 | View |